Prucalopride Tablet, Film Coated
Product Images NDC 0781-8159

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride (NDC 0781-8159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pruca-spl-structure (Pruca Spl Structure)

Chemical structure of prucalopride shown as two structural formulas, including a chlorinated aromatic ring, a piperidine ring, and carboxylic acid groups, representing the active ingredient in prucalopride tablets.*

FDA Label Image

Prucalopride-1mg-label (Prucalopride 1mg Label)

Label for Prucalopride Tablets 1 mg, film-coated oral tablets by Sandoz Inc. The label includes dosage information indicating one tablet once daily, container size with 30 tablets, and storage instructions. It also features a barcode and manufacturing details stating the product is made in India for Sandoz Inc., Princeton, NJ.*

FDA Label Image

Prucalopride-2mg-label (Prucalopride 2mg Label)

Label for Prucalopride tablets, 2 mg film-coated oral tablets. The label states one tablet once daily with a package size of 30 tablets. Manufactured for Sandoz Inc., Princeton, NJ, product of India. Storage instructions and barcode are visible, along with the NDC 0781-8159-31 and no varnish marking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.